[
food and drug administration
]Latest from food and drug administration
US drug regulator postpones meeting on infant Covid vaccines
- The meeting would have evaluated whether two doses of the Covid-19 vaccine shot should be authorised for children aged six months through four years, even though clinical trials are still evaluating whether three shots are needed.
Published on Feb 12, 2022 12:55 AM IST
AFP |
US FDA clears Pfizer's Covid-19 booster shot for 12- to 15-year-olds
The FDA said it reviewed published data and real world evidence on the safety of booster doses provided by the Israeli Ministry of Health including data from over 6,300 individuals 12-to-15 years of age who received a Pfizer shot.
Published on Jan 03, 2022 08:28 PM IST
Reuters |
In a first, US approves AstraZeneca antibody for cases reacting badly to vaccine
The FDA warned the drug Evusheld is “not a substitute for vaccination in individuals for whom Covid-19 vaccination is recommended” and can only be authorized for people who have a weakened immune system or those who cannot be vaccinated for medical reasons, such as a strong allergic reaction.
Published on Dec 09, 2021 07:21 AM IST
AFP |
Pfizer, Moderna booster shots cleared for all US adults. Final hurdle remains
According to the CDC, more than a third of fully vaccinated senior citizens in the US had already received their booster doses as of Thursday, and 17 per cent of fully vaccinated adults overall have had an additional shot of vaccine.
Published on Nov 19, 2021 07:33 PM IST
Written by Joydeep Bose | Edited by Poulomi Ghosh, Hindustan Times, New Delhi
FDA promises quick review of Pfizer booster for all adults, CDC meets Friday
The decision from the FDA will likely come before a US Centers for Disease Control and Prevention (CDC) advisory panel meets on Friday to discuss expanding the eligibility for booster doses of Pfizer/BioNTech's vaccine, currently allowed for select groups of people.
Published on Nov 17, 2021 07:41 AM IST
Reuters |
